Defying the economists: A decrease in heart rate improves not only cardiac but also endothelial function

British Journal of Pharmacology

Volumn 154, Issue 4, 2008, Pages 727-728

  Triggle, C R ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

Cerebral artery; Dyslipidaemia; Endothelial dysfunction; If channel; Ivabradine; Renal artery

Indexed keywords

APOLIPOPROTEIN B100; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IVABRADINE; METOPROLOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANGINA PECTORIS; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN ARTERY; CORONARY ARTERY; CORONARY ARTERY DISEASE; DRUG EFFECT; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HEART RATE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; RENAL ARTERY; STRESS; TACHYCARDIA; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; BENZAZEPINES; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HEART RATE; HUMANS; MICE; SINOATRIAL NODE; VASODILATION;

EID: 45249108656     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.168     Document Type: Note

References (10)

1. Benetos A, Rudnichi A, Thomas F, Safar M, Guize L (1999). Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension 33: 44-52.
2. Berdeaux A (2007). Preclinical results with I(f) current inhibition by ivabradine. Drugs 67 (Suppl 2): 25-33.
3. Brown HF, DiFrancesco D, Noble SJ (1979). How does adrenaline accelerate the heart? Nature 280: 235-236.
4. DiFrancesco D, Borer JS (2007). The funny current: cellular basis for the control of heart rate. Drugs 67 (Suppl 2): 15-24.
5. Drouin A, Gendron M-È, Thorin E, Gillis M-A, Mahlberg-Gaudin F, Tardif J-C (2008). Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice. Br J Pharmacol 154: 749-757.
6. Harzheim D, Pfeiffer KH, Fabritz L, Kremmer E, Buch T, Waisman A et al. (2008). Cardiac pacemaker function of HCN4 channels in mice is confined to embryonic development and requires cyclic AMP. EMBO J 27: 692-703.
7. Krummen S, Falck JR, Thorin E (2005). Two distinct pathways account for EDHF-dependent dilatation in the gracilis artery of dyslipidaemic hApoB+/+ mice. Br J Pharmacol 145: 264-270.
8. Simon L, Ghaleh B, Puybasset L, Giudicelli JF, Berdeaux A (1995). Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther 275: 659-666.
9. Smith C, Teitler M (1999). Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors. Cardiovasc Drugs Ther 13: 123-126.
10. Strawn WB, Bondjers G, Kaplan JR, Manuck SB, Schwenke DC, Hansson GK et al. (1991). Endothelial dysfunction in response to psychosocial stress in monkeys. Circ Res 68: 1270-1279.